Home > Press > Artificial Antibody Delivers Nanoparticles to Tumors
![]() |
Abstract:
Back
Nanotech News
January 2009
Artificial Antibody Delivers Nanoparticles to Tumors
Antibodies that target epidermal growth factor receptor (EGFR) have proven themselves as potent anticancer drugs. Now, a team of investigators led by Shuming Nie, Ph.D., and Lily Yang, Ph.D., both at the Emory University School of Medicine and members of the Emory-Georgia Tech Nanotechnology Center for Personalized and Predictive Oncology, is aiming to capitalize on this targeting ability, using a modified anti-EGFR antibody to delivery nanoparticles into tumor cells.
Reporting its work in the journal Small, the Emory team describes its use of a so-called single-chain antibody to mimic the tumor-targeting properties of a standard anti-EGFR antibody. Standard antibodies are large biomolecules comprising two pairs of two peptide chains known as heavy and light chains. In part because of their large size, antibodies are difficult to work with and often have difficulty accessing the deeper regions of a solid tumor. To overcome these problems, the investigators built an artificial antibody comprising portions of a single heavy chain and a light chain hooked together. This construct is less than 20% of the size and weight of a full antibody, but it retains the larger molecule's binding abilities for EGFR.
With their artificial antibody in hand, the investigators used it as a tumor-targeting agent for two types of nanoparticles—quantum dots, which can be seen using fluorescence imaging, and iron oxide nanoparticles, which can be imaged using standard magnetic resonance imaging (MRI) instruments. The Emory team attached the targeting agent to the nanoparticles using a novel linking technology they developed for this purpose.
With the two types of antibody-linked nanoparticles in hand, the investigators conducted a series of experiments to determine whether these nanoscale constructs would target tumors and whether tumor cells would take up take the antibody-nanoparticle combos. Indeed, targeted nanoparticles homed in quickly on tumors when injected into tumor-bearing mice, whereas untargeted nanoparticles accumulated primarily in the liver and spleen. The targeted nanoparticles also gained rapid entry into tumor cells, whereas the untargeted nanoparticles did not. The nanoparticles were visible using both fluorescence imaging and MRI.
####
About National Cancer Institute
The NCI Alliance for Nanotechnology in Cancer is a comprehensive, systematized initiative encompassing the public and private sectors, designed to accelerate the application of the best capabilities of nanotechnology to cancer.
Currently, scientists are limited in their ability to turn promising molecular discoveries into benefits for cancer patients. Nanotechnology can provide the technical power and tools that will enable those developing new diagnostics, therapeutics, and preventives to keep pace with today’s explosion in knowledge.
For more information, please click here
Contacts:
National Cancer Institute
Office of Technology & Industrial Relations
ATTN: NCI Alliance for Nanotechnology in Cancer
Building 31, Room 10A49
31 Center Drive , MSC 2580
Bethesda , MD 20892-2580
Copyright © National Cancer Institute
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related Links |
Related News Press |
News and information
Flexible electronics integrated with paper-thin structure for use in space January 17th, 2025
Quantum engineers ‘squeeze’ laser frequency combs to make more sensitive gas sensors January 17th, 2025
Imaging
Turning up the signal November 8th, 2024
New discovery aims to improve the design of microelectronic devices September 13th, 2024
Quantum researchers cause controlled ‘wobble’ in the nucleus of a single atom September 13th, 2024
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Discoveries
Quantum engineers ‘squeeze’ laser frequency combs to make more sensitive gas sensors January 17th, 2025
Announcements
Quantum engineers ‘squeeze’ laser frequency combs to make more sensitive gas sensors January 17th, 2025
The National Space Society Congratulates SpaceX on Starship’s 7th Test Flight: Latest Test of the Megarocket Hoped to Demonstrate a Number of New Technologies and Systems January 17th, 2025
![]() |
||
![]() |
||
The latest news from around the world, FREE | ||
![]() |
![]() |
||
Premium Products | ||
![]() |
||
Only the news you want to read!
Learn More |
||
![]() |
||
Full-service, expert consulting
Learn More |
||
![]() |